Under President and CEO Bruce Broussard, Humana Inc. is investing in technology and infrastructure so it can offer more competitive health insurance products—and focus more on value-based care.
“Over the last several years, and particularly throughout 2017, we’ve committed to productivity initiatives designed to promote operational excellence, accelerate our strategy, fund critical initiatives and advance our growth objectives,” Broussard said last week in the company’s third quarter earnings call.
The Louisville, Ken.-based firm is in improvement mode since its merger last year with Aetna Inc. did not work out. Earnings were better than expected, and for 2018, Broussard is confident about the continued strong performance of Humana’s individual Medicare Advantage business.
Humana is also partnering with health care providers to support their transition to value-based care, including making investments in payer-agnostic care coordination technology and analytics capability that enable providers to be successful in the value-based models, Broussard said.
“Throughout 2017, we have been oriented to improving the productivity of the organization,” he said. “There’s a continued need to invest in the business for long-term competitive positioning, whether it’s in technology or it’s in areas that are building capabilities, like in our provider area or even in our home (healthcare) area, which helps us with clinical outcomes.”
Broussard is No. 55 on Chief Executive and RHR International’s CEO1000 Tracker, a ranking of the top 1,000 public/private companies.
President and CEO (Since January 1st, 2013), Humana
Previous position and company: CEO of McKesson Specialty/US Oncology
Start date at previous company 2000
First Position at Previous Company: Chief Financial Officer
Education: BBA from Texas A&M and an MBA from the University of Houston
*External, came from McKesson so changed some of the info